Beacon Therapeutics vs Complement Therapeutics
Beacon Therapeutics
Transforming Vision, Transforming Lives
95 employees · est. 2023 · London, United Kingdom
Complement Therapeutics
Developing the next generation of complement medicines
36 employees · est. 2020 · Germany
Complement Therapeutics is the older company (2023 vs 2020); Beacon Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Beacon Therapeutics | Complement Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2023 | 2020 older |
| Headquarters | ||
| Headquarters | London, United Kingdom | Germany |
| Employees | ||
| Employees | 95 larger | 36 |
| Industry | ||
| Industry | Biotechnology, Health Care, Health and Wellness | Biotechnology |
| Funding Stage | ||
| Funding Stage | Series C | Series A |
| Total Funding | ||
| Total Funding | $341.00M | $77.00M |
| Funding Rounds | ||
| Funding Rounds | 4 | 3 |
| Services | ||
| Services | Not tracked yet | Research and development of complement-related disease therapies, Development of gene and protein-based therapeutic platforms, Mass spectrometry for complement protein measurement |
| Target Customers | ||
| Target Customers | Not tracked yet | Patients with complement-mediated diseases, Individuals with age-related macular degeneration, Healthcare providers specializing in ocular and systemic diseases |
| Taxonomy | ||
| Taxonomy | Ophthalmic Gene TherapyRetinal DiseasesX-linked Retinitis PigmentosaAMD (age-related Macular Degeneration)Cone-rod DystrophyGene Therapy Program +8 | Complement-Mediated DiseasesGene TherapyGeographic AtrophyDry Age-Related Macular DegenerationPrecision MedicineDiagnostic Platform +7 |
| Website | ||
| Website | beacontx.com | complementtx.com |
About Beacon Therapeutics
Beacon Therapeutics is a United States based ophthalmic gene therapy company that aims to restore and enhance the sight of patients suffering from a variety of prevalent and rare retinal diseases leading to blindness. The company's scientific foundation encompasses a late-stage development candidate...
About Complement Therapeutics
Complement Therapeutics, founded in 2020, is a biotechnology company dedicated to pioneering the development of the next generation of complement medicines. Headquartered in Germany, this spinout from the University of Manchester focuses on innovative therapeutics for complement-mediated diseases....
Also comparing in this category
Comparing more than these two?
Get Beacon Therapeutics, Complement Therapeutics and up to nine more competitors side by side in one PDF: team, funding, traffic and every dated move of the last six months. Every company is re-checked on the day you order.
How does Beacon Therapeutics compare?
A PDF of Beacon Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Rival Readout
Comparing competitors? We do this properly.
10 rivals, 90 days of dated moves in 7 business days: a ranked list of what matters, each with its source, ending in a 60-minute readout with your team.
Frequently Asked Questions
Compare Beacon Therapeutics with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Beacon Therapeutics on 9 Jun 2026, and Complement Therapeutics on 28 Jan 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
